Jerónimo Martínez-García

586 total citations
21 papers, 151 citations indexed

About

Jerónimo Martínez-García is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Jerónimo Martínez-García has authored 21 papers receiving a total of 151 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology. Recurrent topics in Jerónimo Martínez-García's work include Ovarian cancer diagnosis and treatment (6 papers), Immune Cell Function and Interaction (5 papers) and CAR-T cell therapy research (4 papers). Jerónimo Martínez-García is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Immune Cell Function and Interaction (5 papers) and CAR-T cell therapy research (4 papers). Jerónimo Martínez-García collaborates with scholars based in Spain, United Kingdom and United States. Jerónimo Martínez-García's co-authors include Lourdes Gimeno, Andrés Redondo, María R. López-Álvarez, José A. Campillo, Manuel Muro, Alfredo Minguela, Jorge Martínez‐Escribano, E.M. Guerra, Luís Manso and Antonio González-Martı́n and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Jerónimo Martínez-García

18 papers receiving 151 citations

Peers

Jerónimo Martínez-García

IMMUN

ONCOL

SURGE

PRM

Francesc Pons Spain

Zhongshao Chen China

Ioannis Kotsopoulos United Kingdom

Claire Hoppenot United States

M.J. Rubio Pérez Spain

Olivia Lauk Switzerland

Angela Polanco United Kingdom

Fengxia Xue China

Fiachra Cooke Ireland

Monika Nowaczyk Poland

Francesc Pons Spain

Jerónimo Martínez-García

18 ×0.3

IMMUN

41 ×0.8

ONCOL

68 ×1.7

SURGE

33 ×1.3

PRM

29 ×1.3

Citations per year, relative to Jerónimo Martínez-García Jerónimo Martínez-García (= 1×) peers Francesc Pons

Countries citing papers authored by Jerónimo Martínez-García

Since Specialization

Citations

This map shows the geographic impact of Jerónimo Martínez-García's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerónimo Martínez-García with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerónimo Martínez-García more than expected).

Fields of papers citing papers by Jerónimo Martínez-García

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerónimo Martínez-García. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerónimo Martínez-García. The network helps show where Jerónimo Martínez-García may publish in the future.

Co-authorship network of co-authors of Jerónimo Martínez-García

This figure shows the co-authorship network connecting the top 25 collaborators of Jerónimo Martínez-García. A scholar is included among the top collaborators of Jerónimo Martínez-García based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerónimo Martínez-García. Jerónimo Martínez-García is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Valabrega, Giorgio, Ignace Vergote, Debra L. Richardson, et al.. (2025). Longer-Term Safety And Efficacy Of Selinexor Maintenance Therapy For Patients With TP53wt Advanced Or Recurrent Endometrial Cancer: Follow-Up Subgroup Analysis Of The ENGOT-EN5/GOG-3055/SIENDO Study. International Journal of Gynecological Cancer. 35(2). 100081–100081. 1 indexed citations

Rubio, María Jesús, Aránzazu Manzano, Purificación Estévez-García, et al.. (2024). Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study. BMC Cancer. 24(1). 803–803.

Chon, Hye Sook, Michael J. Sundborg, Michael S. Gold, et al.. (2024). Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for endometrial cancer (DUO-E/GOG-3041/ENGOT-EN10): Objective response rate and duration of response by mismatch repair status. Gynecologic Oncology. 190. S61–S62. 2 indexed citations

Chon, Hye Sook, Michael J. Sundborg, Michael A. Gold, et al.. (2024). Safety and tolerability of durvalumab + carboplatin/paclitaxel followed by durvalumab ± olaparib in patients with newly diagnosed advanced or recurrent endometrial cancer (EC) in the DUO-E/GOG-3041/ENGOT-EN10 trial.. Journal of Clinical Oncology. 42(16_suppl). 5599–5599. 1 indexed citations

Martín‐Broto, Javier, Jerónimo Martínez-García, David S. Moura, et al.. (2023). Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A. Signal Transduction and Targeted Therapy. 8(1). 405–405. 15 indexed citations

Serrano, César, Rosa Álvarez, Juan Antonio Carrasco, et al.. (2023). SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022). Clinical & Translational Oncology. 25(9). 2707–2717. 3 indexed citations

Fernández, Juan Ángel, et al.. (2023). Incidence Trends and Main Features of Gastro-Intestinal Stromal Tumours in a Mediterranean Region: A Population-Based Study. Cancers. 15(11). 2994–2994. 1 indexed citations

Oaknin, Ana, Laurence Gladieff, Jerónimo Martínez-García, et al.. (2023). VP5-2023: Primary results from BEATcc (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030), a randomised phase III trial of first-line atezolizumab (atezo) combined with a platinum doublet and bevacizumab (bev) for metastatic (stage IVB), persistent or recurrent cervical cancer (R/M CC). Annals of Oncology. 34(12). 1198–1200. 8 indexed citations

Martínez-García, Jerónimo, et al.. (2023). Exercise during treatment for advanced cervical cancer. BMJ Supportive & Palliative Care. 13(e3). e960–e963. 1 indexed citations

10.

Redondo, Andrés, E.M. Guerra, Luís Manso, et al.. (2021). SEOM clinical guideline in ovarian cancer (2020). Clinical & Translational Oncology. 23(5). 961–968. 29 indexed citations

11.

Gimeno, Lourdes, José Luís Fuster, Jerónimo Martínez-García, et al.. (2021). CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients. OncoImmunology. 10(1). 1986943–1986943. 7 indexed citations

12.

Martínez-García, Jerónimo, et al.. (2020). 291P Trastuzumab emtansine in HER2-positive metastatic breast cancer after pertuzumab and trastuzumab: TDM1RM Study. Annals of Oncology. 31. S358–S358.

13.

Cascales-Campos, P.A., et al.. (2020). Urinary and fecal incontinence in patients with advanced ovarian cancer treated with CRS + HIPEC. Surgical Oncology. 36. 115–119. 5 indexed citations

14.

Gimeno, Lourdes, José A. Campillo, Francisco Garcı́a-Cózar, et al.. (2020). KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling. Cancers. 12(10). 2991–2991. 9 indexed citations

15.

Alconchel, Felipe, et al.. (2019). Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies. Hernia. 24(2). 257–263. 10 indexed citations

16.

Gimeno, Lourdes, Juan Cabezas‐Herrera, José A. Campillo, et al.. (2019). Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers. European Urology Oncology. 4(2). 246–255. 16 indexed citations

17.

Gimeno, Lourdes, José A. Campillo, Jerónimo Martínez-García, et al.. (2019). Activating KIRs on Educated NK Cells Support Downregulation of CD226 and Inefficient Tumor Immunosurveillance. Cancer Immunology Research. 7(8). 1307–1317. 12 indexed citations

18.

Gimeno, Lourdes, Anna Mrowiec, Jerónimo Martínez-García, et al.. (2018). NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome. Cancer Immunology Research. 6(12). 1537–1547. 26 indexed citations

19.

Martínez-García, Jerónimo, et al.. (2015). 455 Reversal of azd6244 (selumetinib) resistance in primary cultures of colorectal cancer, by p70s6 kinase inhibition using bez-235. European Journal of Cancer. 51. S96–S97. 1 indexed citations

20.

Carmona‐Bayonas, Alberto, Paula Fonseca, Carme Font, et al.. (2014). Bacteremia in adult cancer patients with apparently stable febrile neutropenia: data from a cohort of 692 consecutive episodes from a single institution. The Journal of Community and Supportive Oncology. 12(9). 312–320. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact